Post-Surgical Pain Clinical Trials

A listing of Post-Surgical Pain medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Sheffield Alabama 35660

Patients are needed to participate in a clinical research study of AYX1 Injection 660 mg/6 mL and Placebo Injection 6 mL to evaluate Post-surgical Pain

Arizona

Phoenix Arizona 85023

Patients are needed to participate in a clinical research study of AYX1 Injection 660 mg/6 mL and Placebo Injection 6 mL to evaluate Post-surgical Pain

California

Encinitas California 92024

Patients are needed to participate in a clinical research study of AYX1 Injection 660 mg/6 mL and Placebo Injection 6 mL to evaluate Post-surgical Pain

Florida

University of South Florida - South Tampa Center for Advanced Healthcare
Tampa Florida 33606

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety of N1539 Following Major Surgery

Pensacola Florida 32503

Patients are needed to participate in a clinical research study of AYX1 Injection 660 mg/6 mL and Placebo Injection 6 mL to evaluate Post-surgical Pain

Tamarac Florida 33321

Patients are needed to participate in a clinical research study of AYX1 Injection 660 mg/6 mL and Placebo Injection 6 mL to evaluate Post-surgical Pain

Mississippi

Jackson Mississippi 39202

Patients are needed to participate in a clinical research study of AYX1 Injection 660 mg/6 mL and Placebo Injection 6 mL to evaluate Post-surgical Pain

Ohio

Columbus Ohio 43210

Patients are needed to participate in a clinical research study of AYX1 Injection 660 mg/6 mL and Placebo Injection 6 mL to evaluate Post-surgical Pain

Pennsylvania

Urologic Consultants of Southeastern Pennsylvania
Bala Cynwyd Pennsylvania 19004

A Multicenter, Multi-Arm, Randomized, Multi-Dose, Placebo-Controlled, Double-Blind, Phase 3 Study of Intravesical Apaziquone (EOquin®) as a Surgical Adjuvant in the Immediate Postoperative Period in Patients Undergoing TURBT. Clinical trial NCT02563561,SPI-EOQ-13-305.